| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 249.6 | 190.0 |
| Profit before tax | 26.4 | 21.7 |
| Net income | 28.6 | 22.5 |
| EPS (diluted, $ a share) | $0.11 | $0.09 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +26.9% |
|---|---|
| Revenue, year on year | +31.3% |
10-Q filed with the SEC, NASDAQ: SBRA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Sabra Health Care REIT, Inc.: key numbers
- Share price
- $20.35Close, Nov 16
- Market cap
- $5.33B
- Shares outstanding
- 261.96MLatest SEC cover page
- Sector
- Real Estate & Construction
- Industry
- Real Estate Investment TrustsSIC 6798
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Sabra Health Care REIT, Inc.
All →Sabra Health Care REIT Insider Michael J. Foster Sells $210K of Stock
Michael J. Foster sold 10,000 shares of Sabra Health Care REIT, Inc. at $20.98 a share, worth $210K in total on Nov 11, 2026. Shares held after the trade: 72,834 (-12.1%).
- Value
- $210K
- Shares
- 10,000
- Price
- $20.98
- Holding change
- -12.1%
- Trade date
- Nov 11, 2026
Sabra Health Care REIT Earnings Call: Key Takeaways
Sabra Health Care REIT delivered strong Q3 2026 results, driven by 14.6% same-store SHOP NOI growth and a robust $1.17 billion investment pipeline.
- Call
- Nov 3, 2026, 1:00 PM ET
Sabra Health Care REIT Financial Results
Sabra Health Care REIT reported Q3 2026 net income of $0.11 per diluted share and Normalized AFFO of $0.41 per share. The company updated its full-year 2026 guidance, raising its Normalized AFFO range to $1.600 - $1.610 per share, and highlighted $747.2 million in year-to-date investments with an 8.0% estimated yield.
- Term
- Q3 2026